speb/financial-data huggingface dataset:
REAX income_statement (annual, 2025-12-31) — Cost Of Revenue: 1802728000.00
REAX income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 466105000.00
REAX balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 38205000.00
REAX balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 38205000.00
REAX balance_sheet (annual, 2025-12-31) — Current Assets: 105764000.00
REAX balance_sheet (quarterly, 2025-12-31) — Current Assets: 105764000.00
REAX balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 26338000.00
REAX balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 26338000.00
REAX balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 26338000.00
REAX balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 26338000.00
REAX balance_sheet (annual, 2025-12-31) — Current Liabilities: 75266000.00
REAX balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 75266000.00
REAX cash_flow (annual, 2025-12-31) — Depreciation: 761000.00
REAX cash_flow (quarterly, 2025-12-31) — Depreciation: 224000.00
REAX cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 1929000.00
REAX cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 585000.00
REAX income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 1929000.00
REAX income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 585000.00
REAX cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 1929000.00
REAX cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 585000.00
REAX income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 1929000.00
REAX income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 585000.00
REAX income_statement (annual, 2025-12-31) — Depreciation Income Statement: 1929000.00
REAX income_statement (annual, 2025-12-31) — Diluted Average Shares: 219873000.00
REAX income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 221311000.00
REAX income_statement (annual, 2025-12-31) — Diluted EPS: -0.04
REAX income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.02
REAX income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -8105000.00
REAX income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -4203000.00
REAX income_statement (annual, 2025-12-31) — EBIT: -8252000.00
REAX income_statement (quarterly, 2025-12-31) — EBIT: -4907000.00
REAX income_statement (annual, 2025-12-31) — EBITDA: -6323000.00
REAX income_statement (quarterly, 2025-12-31) — EBITDA: -4322000.00
REAX cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 2000.00
REAX cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 109000.00
REAX cash_flow (annual, 2025-12-31) — End Cash Position: 59551000.00
REAX cash_flow (quarterly, 2025-12-31) — End Cash Position: 59551000.00
REAX cash_flow (annual, 2025-12-31) — Financing Cash Flow: -40248000.00
REAX cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -15451000.00
REAX cash_flow (annual, 2025-12-31) — Free Cash Flow: 62076000.00
REAX cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -16000.00
REAX balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 318000.00
REAX balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 318000.00
REAX income_statement (annual, 2025-12-31) — General And Administrative Expense: 89003000.00
REAX income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 22438000.00
REAX balance_sheet (annual, 2025-12-31) — Goodwill: 8993000.00
REAX balance_sheet (quarterly, 2025-12-31) — Goodwill: 8993000.00
REAX balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 13150000.00
REAX balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 13150000.00
REAX balance_sheet (annual, 2025-12-31) — Gross PPE: 4179000.00
REAX balance_sheet (quarterly, 2025-12-31) — Gross PPE: 4179000.00
REAX income_statement (annual, 2025-12-31) — Gross Profit: 165688000.00
REAX income_statement (quarterly, 2025-12-31) — Gross Profit: 39034000.00
REAX income_statement (annual, 2025-12-31) — Interest Expense: 554000.00
REAX income_statement (quarterly, 2025-12-31) — Interest Expense: 137000.00
REAX income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 554000.00
REAX income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 137000.00
REAX balance_sheet (annual, 2025-12-31) — Invested Capital: 51675000.00
REAX balance_sheet (quarterly, 2025-12-31) — Invested Capital: 51675000.00
REAX cash_flow (annual, 2025-12-31) — Investing Cash Flow: -13594000.00
REAX cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 2372000.00
REAX balance_sheet (annual, 2025-12-31) — Investments And Advances: 2250000.00
REAX balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 2250000.00
REAX balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 2250000.00
REAX balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 2250000.00
REAX balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 4179000.00
REAX balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 4179000.00
REAX balance_sheet (annual, 2025-12-31) — Minority Interest: -90000.00
REAX balance_sheet (quarterly, 2025-12-31) — Minority Interest: -90000.00
REAX income_statement (annual, 2025-12-31) — Minority Interests: -39000.00
REAX income_statement (quarterly, 2025-12-31) — Minority Interests: 12000.00
REAX cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -39363000.00
REAX cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -15064000.00
REAX income_statement (annual, 2025-12-31) — Net Income: -8105000.00
REAX income_statement (quarterly, 2025-12-31) — Net Income: -4203000.00
REAX income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -8105000.00
REAX income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -4203000.00
REAX income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -8066000.00
REAX income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -4215000.00
REAX income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -8105000.00
REAX income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -4203000.00
REAX income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -8105000.00
REAX income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -4203000.00
REAX cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -8066000.00
REAX cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -4215000.00
REAX income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -8066000.00
REAX income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -4215000.00
REAX cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: -2750000.00
REAX cash_flow (quarterly, 2025-12-31) — Net Intangibles Purchase And Sale: 0.00
REAX income_statement (annual, 2025-12-31) — Net Interest Income: -554000.00
REAX income_statement (quarterly, 2025-12-31) — Net Interest Income: -137000.00
REAX cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -9744000.00
REAX cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 2537000.00
REAX income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -554000.00
REAX income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -137000.00
REAX cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -3054000.00
REAX cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -985000.00
REAX balance_sheet (annual, 2025-12-31) — Net PPE: 2455000.00
REAX balance_sheet (quarterly, 2025-12-31) — Net PPE: 2455000.00
REAX cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -1100000.00
REAX cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -165000.00
REAX balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 38525000.00
REAX balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 38525000.00
REAX balance_sheet (annual, 2025-12-31) — Non Current Accounts Receivable: 2311000.00
REAX balance_sheet (quarterly, 2025-12-31) — Non Current Accounts Receivable: 2311000.00
REAX balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 931000.00
REAX balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 931000.00
REAX balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 10000.00
REAX balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 10000.00
REAX balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 931000.00
REAX balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 931000.00
REAX balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 10000.00
REAX balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 10000.00
REAX income_statement (annual, 2025-12-31) — Normalized EBITDA: -5573000.00
REAX income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -3572000.00
REAX income_statement (annual, 2025-12-31) — Normalized Income: -7418000.00
REAX income_statement (quarterly, 2025-12-31) — Normalized Income: -3576265.27
REAX cash_flow (annual, 2025-12-31) — Operating Cash Flow: 65926000.00
REAX cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 149000.00
REAX income_statement (annual, 2025-12-31) — Operating Income: -8497000.00
REAX income_statement (quarterly, 2025-12-31) — Operating Income: -4499000.00
REAX income_statement (annual, 2025-12-31) — Operating Revenue: 1968416000.00
REAX income_statement (quarterly, 2025-12-31) — Operating Revenue: 505139000.00
REAX balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 210478000.00
REAX balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 210478000.00
REAX balance_sheet (annual, 2025-12-31) — Other Current Assets: 3081000.00
REAX balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 3081000.00
REAX balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 318000.00
REAX balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 318000.00
REAX income_statement (annual, 2025-12-31) — Other Gand A: 25111000.00
REAX income_statement (quarterly, 2025-12-31) — Other Gand A: 5727000.00
REAX income_statement (annual, 2025-12-31) — Other Income Expense: 245000.00
REAX income_statement (quarterly, 2025-12-31) — Other Income Expense: -408000.00
REAX balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 4157000.00
REAX balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 4157000.00
REAX cash_flow (annual, 2025-12-31) — Other Non Cash Items: -180000.00
REAX cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -99000.00
REAX income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 995000.00
REAX income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 342000.00
REAX balance_sheet (annual, 2025-12-31) — Other Payable: 9562000.00
REAX balance_sheet (quarterly, 2025-12-31) — Other Payable: 9562000.00
REAX balance_sheet (annual, 2025-12-31) — Other Receivables: 6231000.00
REAX balance_sheet (quarterly, 2025-12-31) — Other Receivables: 6231000.00
REAX balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 16731000.00
REAX balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 16731000.00
REAX income_statement (annual, 2025-12-31) — Other Special Charges: 750000.00
REAX balance_sheet (annual, 2025-12-31) — Payables: 10723000.00
REAX balance_sheet (quarterly, 2025-12-31) — Payables: 10723000.00
REAX balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 48928000.00
REAX balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 48928000.00
REAX income_statement (annual, 2025-12-31) — Pretax Income: -8806000.00
REAX income_statement (quarterly, 2025-12-31) — Pretax Income: -5044000.00
REAX cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 2169000.00
REAX cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 598000.00
REAX cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: -2750000.00
REAX cash_flow (quarterly, 2025-12-31) — Purchase Of Intangibles: 0.00
REAX cash_flow (annual, 2025-12-31) — Purchase Of Investment: -18303000.00
REAX cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -269000.00
REAX cash_flow (annual, 2025-12-31) — Purchase Of PPE: -1100000.00
REAX cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -165000.00
REAX balance_sheet (annual, 2025-12-31) — Receivables: 26401000.00
REAX balance_sheet (quarterly, 2025-12-31) — Receivables: 26401000.00
REAX income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 1802728000.00
REAX income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 466105000.00
REAX income_statement (annual, 2025-12-31) — Reconciled Depreciation: 1929000.00
REAX income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 585000.00
REAX cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -39363000.00
REAX cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -15064000.00
REAX income_statement (annual, 2025-12-31) — Research And Development: 17443000.00
REAX income_statement (quarterly, 2025-12-31) — Research And Development: 4806000.00
REAX balance_sheet (annual, 2025-12-31) — Restricted Cash: 26338000.00
REAX balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 26338000.00
REAX balance_sheet (annual, 2025-12-31) — Retained Earnings: -112851000.00
REAX balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -112851000.00
REAX income_statement (annual, 2025-12-31) — Salaries And Wages: 63892000.00
REAX income_statement (quarterly, 2025-12-31) — Salaries And Wages: 16711000.00
REAX cash_flow (annual, 2025-12-31) — Sale Of Investment: 8559000.00
REAX cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 2806000.00
REAX income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 65810000.00
REAX income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 15704000.00
REAX income_statement (annual, 2025-12-31) — Selling General And Administration: 154813000.00
REAX income_statement (quarterly, 2025-12-31) — Selling General And Administration: 38142000.00
REAX balance_sheet (annual, 2025-12-31) — Share Issued: 210478000.00
REAX balance_sheet (quarterly, 2025-12-31) — Share Issued: 210478000.00
REAX income_statement (annual, 2025-12-31) — Special Income Charges: -750000.00
REAX income_statement (quarterly, 2025-12-31) — Special Income Charges: -750000.00
REAX cash_flow (annual, 2025-12-31) — Stock Based Compensation: 68146000.00
REAX cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 17732000.00
REAX balance_sheet (annual, 2025-12-31) — Stockholders Equity: 51675000.00
REAX balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 51675000.00
REAX balance_sheet (annual, 2025-12-31) — Tangible Book Value: 38525000.00
REAX balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 38525000.00
REAX income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -63000.00
REAX income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -123265.27
REAX income_statement (annual, 2025-12-31) — Tax Provision: -740000.00
REAX income_statement (quarterly, 2025-12-31) — Tax Provision: -829000.00
REAX income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.08
REAX income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.16
REAX balance_sheet (annual, 2025-12-31) — Total Assets: 126861000.00
REAX balance_sheet (quarterly, 2025-12-31) — Total Assets: 126861000.00
REAX balance_sheet (annual, 2025-12-31) — Total Capitalization: 51675000.00
REAX balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 51675000.00
REAX balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 51585000.00
REAX balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 51585000.00
REAX income_statement (annual, 2025-12-31) — Total Expenses: 1976913000.00
REAX income_statement (quarterly, 2025-12-31) — Total Expenses: 509638000.00
REAX balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 75276000.00
REAX balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 75276000.00
REAX balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 21097000.00
REAX balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 21097000.00
REAX balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 10000.00
REAX balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 10000.00
REAX income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -9247000.00
REAX income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -5249000.00
REAX income_statement (annual, 2025-12-31) — Total Unusual Items: -750000.00
REAX income_statement (quarterly, 2025-12-31) — Total Unusual Items: -750000.00
REAX income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -750000.00
REAX income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -750000.00
REAX balance_sheet (annual, 2025-12-31) — Treasury Stock: 0.00
REAX balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 0.00
REAX cash_flow (annual, 2025-12-31) — Unrealized Gain Loss On Investment Securities: -921000.00
REAX balance_sheet (annual, 2025-12-31) — Working Capital: 30498000.00
REAX balance_sheet (quarterly, 2025-12-31) — Working Capital: 30498000.00
REAX income_statement (quarterly, 2026-03-31) — +Operating Expense: 45283000.00
REAX income_statement (quarterly, 2026-03-31) — +Total Revenue: 465551000.00
REAX balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 931000.00
REAX balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 25185000.00
REAX balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -1950000.00
REAX balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 181262000.00
REAX cash_flow (quarterly, 2026-03-31) — Asset Impairment Charge: 12000.00
REAX income_statement (quarterly, 2026-03-31) — Basic Average Shares: 223688000.00
REAX income_statement (quarterly, 2026-03-31) — Basic EPS: -0.02
REAX cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 59551000.00
REAX cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -238000.00
REAX balance_sheet (quarterly, 2026-03-31) — Capital Stock: 0.00
REAX balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 46016000.00
REAX balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 62920000.00
REAX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 69000.00
REAX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -337000.00
REAX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 23280000.00
REAX cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -230000.00
REAX cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: 10788000.00
REAX cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: 295000.00
REAX cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 10467000.00
REAX cash_flow (quarterly, 2026-03-31) — Change In Payable: -5203000.00
REAX cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 5585000.00
REAX cash_flow (quarterly, 2026-03-31) — Change In Receivables: -7248000.00
REAX cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 9099000.00
REAX cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -5015000.00
REAX cash_flow (quarterly, 2026-03-31) — Changes In Cash: 23012000.00
REAX balance_sheet (quarterly, 2026-03-31) — Common Stock: 0.00
REAX balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 65691000.00
REAX cash_flow (quarterly, 2026-03-31) — Common Stock Payments: 0.00
REAX income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 423396000.00
REAX balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 48993000.00
REAX balance_sheet (quarterly, 2026-03-31) — Current Assets: 136704000.00
REAX balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 36805000.00
REAX balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 36805000.00
REAX balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 91318000.00
REAX cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 575000.00
REAX income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 575000.00
REAX cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 575000.00
REAX income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 575000.00
REAX income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 223688000.00
REAX income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.02
REAX income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -3421000.00
REAX income_statement (quarterly, 2026-03-31) — EBIT: -3328000.00
REAX income_statement (quarterly, 2026-03-31) — EBITDA: -2753000.00
REAX cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: 258000.00
REAX cash_flow (quarterly, 2026-03-31) — End Cash Position: 82821000.00
REAX cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 69000.00
REAX cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 23042000.00
REAX balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 701000.00
REAX income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 23283000.00
REAX balance_sheet (quarterly, 2026-03-31) — Goodwill: 8993000.00
REAX balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 12805000.00
REAX balance_sheet (quarterly, 2026-03-31) — Gross PPE: 4401000.00
REAX income_statement (quarterly, 2026-03-31) — Gross Profit: 42155000.00
REAX income_statement (quarterly, 2026-03-31) — Interest Expense: 86000.00
REAX income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 86000.00
REAX balance_sheet (quarterly, 2026-03-31) — Invested Capital: 65691000.00
REAX cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -337000.00
REAX balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 2250000.00
REAX balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 2250000.00
REAX balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 4401000.00
REAX balance_sheet (quarterly, 2026-03-31) — Minority Interest: -111000.00
REAX income_statement (quarterly, 2026-03-31) — Minority Interests: 37000.00
REAX cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 0.00
REAX income_statement (quarterly, 2026-03-31) — Net Income: -3421000.00
REAX income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -3421000.00
REAX income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -3458000.00
REAX income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -3421000.00
REAX income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -3421000.00
REAX cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -3458000.00
REAX income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -3458000.00
REAX income_statement (quarterly, 2026-03-31) — Net Interest Income: -86000.00
REAX cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -99000.00
REAX income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -86000.00
REAX cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: 16000.00
REAX balance_sheet (quarterly, 2026-03-31) — Net PPE: 2451000.00
REAX cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -238000.00
REAX balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 52886000.00
REAX balance_sheet (quarterly, 2026-03-31) — Non Current Accounts Receivable: 1767000.00
REAX balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 931000.00
REAX balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 10000.00
REAX balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 931000.00
REAX balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 10000.00
REAX income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -2441000.00
REAX income_statement (quarterly, 2026-03-31) — Normalized Income: -3233800.00
REAX cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 23280000.00
REAX income_statement (quarterly, 2026-03-31) — Operating Income: -3128000.00
REAX income_statement (quarterly, 2026-03-31) — Operating Revenue: 465551000.00
REAX balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 213498000.00
REAX balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 2786000.00
REAX balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 701000.00
REAX income_statement (quarterly, 2026-03-31) — Other Gand A: 5685000.00
REAX income_statement (quarterly, 2026-03-31) — Other Income Expense: -200000.00
REAX balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 3812000.00
REAX cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 51000.00
REAX income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 112000.00
REAX balance_sheet (quarterly, 2026-03-31) — Other Payable: 4589000.00
REAX balance_sheet (quarterly, 2026-03-31) — Other Receivables: 9008000.00
REAX balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 16904000.00
REAX balance_sheet (quarterly, 2026-03-31) — Payables: 5520000.00
REAX balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 54513000.00
REAX income_statement (quarterly, 2026-03-31) — Pretax Income: -3414000.00
REAX cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 53000.00
REAX cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -5414000.00
REAX cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -238000.00
REAX balance_sheet (quarterly, 2026-03-31) — Receivables: 34193000.00
REAX income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 423396000.00
REAX income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 575000.00
REAX cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: 0.00
REAX income_statement (quarterly, 2026-03-31) — Research And Development: 5147000.00
REAX balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 36805000.00
REAX income_statement (quarterly, 2026-03-31) — Restructuring And Mergern Acquisition: 312000.00
REAX balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -116272000.00
REAX income_statement (quarterly, 2026-03-31) — Salaries And Wages: 17598000.00
REAX cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 5315000.00
REAX income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 16278000.00
REAX income_statement (quarterly, 2026-03-31) — Selling General And Administration: 39561000.00
REAX balance_sheet (quarterly, 2026-03-31) — Share Issued: 213498000.00
REAX income_statement (quarterly, 2026-03-31) — Special Income Charges: -312000.00
REAX cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 17001000.00
REAX balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 65691000.00
REAX balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 52886000.00
REAX income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -124800.00
REAX income_statement (quarterly, 2026-03-31) — Tax Provision: 44000.00
REAX income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
REAX balance_sheet (quarterly, 2026-03-31) — Total Assets: 156908000.00
REAX balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 65691000.00
REAX balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 65580000.00
REAX income_statement (quarterly, 2026-03-31) — Total Expenses: 468679000.00
REAX balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 91328000.00
REAX balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 20204000.00
REAX balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 10000.00
REAX income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -3440000.00
REAX income_statement (quarterly, 2026-03-31) — Total Unusual Items: -312000.00
REAX income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -312000.00
REAX balance_sheet (quarterly, 2026-03-31) — Working Capital: 45386000.00
REBN income_statement (annual, 2021-12-31) — Depreciation Amortization Depletion Income Statement: 174696.00
REBN income_statement (annual, 2021-12-31) — Depreciation And Amortization In Income Statement: 174696.00
REBN income_statement (annual, 2021-12-31) — Depreciation Income Statement: 174696.00
REBN cash_flow (annual, 2021-12-31) — Operating Gains Losses: 867383.00
REBN income_statement (annual, 2021-12-31) — Other Special Charges: 867383.00
REBN income_statement (annual, 2021-12-31) — Otherunder Preferred Stock Dividend: 0.00
REBN balance_sheet (annual, 2021-12-31) — Prepaid Assets: 191838.00
REBN income_statement (annual, 2021-12-31) — Rent And Landing Fees: 97824.00
REBN income_statement (annual, 2021-12-31) — Rent Expense Supplemental: 649893.00
REBN cash_flow (annual, 2021-12-31) — Short Term Debt Issuance: 0.00
REBN income_statement (annual, 2022-12-31) — +Operating Expense: 5663950.00
REBN income_statement (annual, 2022-12-31) — +Total Revenue: 3240523.00
REBN balance_sheet (annual, 2022-12-31) — Accounts Payable: 87809.00
REBN balance_sheet (annual, 2022-12-31) — Accounts Receivable: 780.00
REBN balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -871138.00
REBN balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 16317014.00
REBN balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: 0.00
REBN income_statement (annual, 2022-12-31) — Basic Average Shares: 1521628.00
REBN income_statement (annual, 2022-12-31) — Basic EPS: -2.32
REBN cash_flow (annual, 2022-12-31) — Beginning Cash Position: 905051.00
REBN cash_flow (annual, 2022-12-31) — Capital Expenditure: -681531.00
REBN balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 3154877.00
REBN balance_sheet (annual, 2022-12-31) — Capital Stock: 1316.00
REBN balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 3019035.00
REBN balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 3019035.00
REBN cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 6092573.00
REBN cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -681531.00
REBN cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -3297057.00
REBN cash_flow (annual, 2022-12-31) — Change In Account Payable: 42062.00
REBN cash_flow (annual, 2022-12-31) — Change In Accrued Expense: 108518.00
REBN cash_flow (annual, 2022-12-31) — Change In Inventory: -43466.00
REBN cash_flow (annual, 2022-12-31) — Change In Payable: 42062.00
REBN cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 150580.00
REBN cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -521176.00
REBN cash_flow (annual, 2022-12-31) — Change In Receivables: -780.00
REBN cash_flow (annual, 2022-12-31) — Change In Working Capital: -414842.00
REBN cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -780.00
REBN cash_flow (annual, 2022-12-31) — Changes In Cash: 2113984.00
REBN balance_sheet (annual, 2022-12-31) — Common Stock: 1316.00
REBN balance_sheet (annual, 2022-12-31) — Common Stock Equity: 4286529.00
REBN cash_flow (annual, 2022-12-31) — Common Stock Issuance: 7200000.00
REBN balance_sheet (annual, 2022-12-31) — Construction In Progress: 251745.00
REBN income_statement (annual, 2022-12-31) — Cost Of Revenue: 1117115.00
REBN balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 233053.00
REBN balance_sheet (annual, 2022-12-31) — Current Assets: 3630008.00
REBN balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 624892.00
REBN balance_sheet (annual, 2022-12-31) — Current Debt: 120402.00
REBN balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 745294.00
REBN balance_sheet (annual, 2022-12-31) — Current Liabilities: 1066156.00
REBN cash_flow (annual, 2022-12-31) — Depreciation: 210616.00
REBN cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 210616.00
REBN cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 210616.00
REBN income_statement (annual, 2022-12-31) — Diluted Average Shares: 1521628.00
REBN income_statement (annual, 2022-12-31) — Diluted EPS: -2.32
REBN income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -3554897.00
REBN income_statement (annual, 2022-12-31) — EBIT: -3524102.00
REBN income_statement (annual, 2022-12-31) — EBITDA: -3313486.00
REBN cash_flow (annual, 2022-12-31) — End Cash Position: 3019035.00
REBN cash_flow (annual, 2022-12-31) — Financing Cash Flow: 6092573.00
REBN cash_flow (annual, 2022-12-31) — Free Cash Flow: -3978589.00
REBN income_statement (annual, 2022-12-31) — Gain On Sale Of Ppe: 0.00
REBN income_statement (annual, 2022-12-31) — General And Administrative Expense: 5663950.00
REBN balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 780.00
REBN balance_sheet (annual, 2022-12-31) — Gross PPE: 5463507.00
REBN income_statement (annual, 2022-12-31) — Gross Profit: 2123408.00
REBN cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 1600.00
REBN income_statement (annual, 2022-12-31) — Interest Expense: 29195.00
REBN income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 29195.00
REBN cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 8500.00
REBN balance_sheet (annual, 2022-12-31) — Inventory: 132343.00
REBN balance_sheet (annual, 2022-12-31) — Invested Capital: 4981802.00
REBN cash_flow (annual, 2022-12-31) — Investing Cash Flow: -681531.00
REBN cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 7200000.00
REBN cash_flow (annual, 2022-12-31) — Issuance Of Debt: 948176.00
REBN balance_sheet (annual, 2022-12-31) — Leases: 639602.00
REBN balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 2529985.00
REBN balance_sheet (annual, 2022-12-31) — Long Term Debt: 574871.00
REBN balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 3104856.00
REBN cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 948176.00
REBN cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -1057733.00
REBN balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 1261596.00
REBN cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 7200000.00
REBN income_statement (annual, 2022-12-31) — Net Income: -3554897.00
REBN income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -3554897.00
REBN income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -3554897.00
REBN income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -3554897.00
REBN income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -3554897.00
REBN cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -3554897.00
REBN income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -3554897.00
REBN income_statement (annual, 2022-12-31) — Net Interest Income: -29195.00
REBN cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -109557.00
REBN cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -109557.00
REBN income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -29195.00
REBN cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -997870.00
REBN balance_sheet (annual, 2022-12-31) — Net PPE: 4592369.00
REBN cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -681531.00
REBN cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 0.00
REBN balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 4286529.00
REBN income_statement (annual, 2022-12-31) — Normalized EBITDA: -3313486.00
REBN income_statement (annual, 2022-12-31) — Normalized Income: -3554897.00
REBN cash_flow (annual, 2022-12-31) — Operating Cash Flow: -3297058.00
REBN income_statement (annual, 2022-12-31) — Operating Income: -3540542.00
REBN income_statement (annual, 2022-12-31) — Operating Revenue: 3240523.00
REBN balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 1645390.00
REBN balance_sheet (annual, 2022-12-31) — Other Current Assets: 477850.00
REBN balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 120402.00
REBN income_statement (annual, 2022-12-31) — Other Gand A: 5663950.00
REBN income_statement (annual, 2022-12-31) — Other Income Expense: 16440.00
REBN cash_flow (annual, 2022-12-31) — Other Non Cash Items: 21064.00
REBN balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 235164.00
REBN income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 16440.00
REBN balance_sheet (annual, 2022-12-31) — Other Properties: 3310564.00
REBN balance_sheet (annual, 2022-12-31) — Payables: 87809.00
REBN balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 320862.00
REBN balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
REBN income_statement (annual, 2022-12-31) — Pretax Income: -3553297.00
REBN balance_sheet (annual, 2022-12-31) — Properties: 0.00
REBN cash_flow (annual, 2022-12-31) — Purchase Of PPE: -681531.00
REBN balance_sheet (annual, 2022-12-31) — Receivables: 780.00
REBN income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 1117115.00
REBN income_statement (annual, 2022-12-31) — Reconciled Depreciation: 210616.00
REBN cash_flow (annual, 2022-12-31) — Repayment Of Debt: -1057733.00
REBN balance_sheet (annual, 2022-12-31) — Retained Earnings: -12031801.00
REBN income_statement (annual, 2022-12-31) — Selling General And Administration: 5663950.00
REBN balance_sheet (annual, 2022-12-31) — Share Issued: 1645390.00
REBN cash_flow (annual, 2022-12-31) — Short Term Debt Issuance: 685961.00
REBN cash_flow (annual, 2022-12-31) — Short Term Debt Payments: -685961.00
REBN income_statement (annual, 2022-12-31) — Special Income Charges: 0.00
REBN cash_flow (annual, 2022-12-31) — Stock Based Compensation: 441001.00
REBN balance_sheet (annual, 2022-12-31) — Stockholders Equity: 4286529.00
REBN balance_sheet (annual, 2022-12-31) — Tangible Book Value: 4286529.00
REBN income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
REBN income_statement (annual, 2022-12-31) — Tax Provision: 1600.00
REBN income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
REBN balance_sheet (annual, 2022-12-31) — Total Assets: 8457541.00
REBN balance_sheet (annual, 2022-12-31) — Total Capitalization: 4861400.00
REBN balance_sheet (annual, 2022-12-31) — Total Debt: 3850150.00
REBN balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 4286529.00
REBN income_statement (annual, 2022-12-31) — Total Expenses: 6781065.00
REBN balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 4171012.00
REBN balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 4827533.00
REBN balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 3104856.00
REBN income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -3540542.00
REBN income_statement (annual, 2022-12-31) — Total Unusual Items: 0.00
REBN income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 0.00
REBN balance_sheet (annual, 2022-12-31) — Working Capital: 2563852.00
REBN income_statement (annual, 2023-12-31) — +Operating Expense: 8162523.00
REBN income_statement (annual, 2023-12-31) — +Total Revenue: 5508139.00
REBN balance_sheet (annual, 2023-12-31) — Accounts Payable: 632753.00
REBN balance_sheet (annual, 2023-12-31) — Accounts Receivable: 56938.00
REBN balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -1110131.00
REBN balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 17603143.00
REBN balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: 0.00
REBN income_statement (annual, 2023-12-31) — Basic Average Shares: 1652034.00
REBN income_statement (annual, 2023-12-31) — Basic EPS: -2.86
REBN cash_flow (annual, 2023-12-31) — Beginning Cash Position: 3019035.00
REBN cash_flow (annual, 2023-12-31) — Capital Expenditure: -2413257.00
REBN balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 4728906.00
REBN balance_sheet (annual, 2023-12-31) — Capital Stock: 187.00
REBN balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 164301.00
REBN balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 164301.00
REBN cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 2737526.00
REBN cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -2413257.00
REBN cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -3179003.00
REBN cash_flow (annual, 2023-12-31) — Change In Account Payable: 544944.00
REBN cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 378237.00
REBN cash_flow (annual, 2023-12-31) — Change In Inventory: -52718.00
REBN cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -71822.00
REBN cash_flow (annual, 2023-12-31) — Change In Payable: 544944.00
REBN cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 923181.00
REBN cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -1069354.00
REBN cash_flow (annual, 2023-12-31) — Change In Receivables: -56158.00
REBN cash_flow (annual, 2023-12-31) — Change In Working Capital: 742483.00
REBN cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -56158.00
REBN cash_flow (annual, 2023-12-31) — Changes In Cash: -2854734.00
REBN balance_sheet (annual, 2023-12-31) — Common Stock: 187.00
REBN balance_sheet (annual, 2023-12-31) — Common Stock Equity: 846406.00
REBN cash_flow (annual, 2023-12-31) — Common Stock Issuance: 0.00
REBN balance_sheet (annual, 2023-12-31) — Construction In Progress: 440700.00
REBN income_statement (annual, 2023-12-31) — Cost Of Revenue: 1888395.00
REBN balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 611290.00
REBN balance_sheet (annual, 2023-12-31) — Current Assets: 765424.00
REBN balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 1003753.00
REBN balance_sheet (annual, 2023-12-31) — Current Debt: 1576117.00
REBN balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 2579870.00
REBN balance_sheet (annual, 2023-12-31) — Current Liabilities: 3823913.00
REBN cash_flow (annual, 2023-12-31) — Depreciation: 262019.00
REBN cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 262019.00
REBN cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 262019.00
REBN income_statement (annual, 2023-12-31) — Diluted Average Shares: 1652034.00
REBN income_statement (annual, 2023-12-31) — Diluted EPS: -2.86
REBN income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -4725123.00
REBN income_statement (annual, 2023-12-31) — EBIT: -4587815.00
REBN income_statement (annual, 2023-12-31) — EBITDA: -4325796.00
REBN cash_flow (annual, 2023-12-31) — End Cash Position: 164301.00
REBN cash_flow (annual, 2023-12-31) — Financing Cash Flow: 2737526.00
REBN cash_flow (annual, 2023-12-31) — Free Cash Flow: -5592260.00
REBN income_statement (annual, 2023-12-31) — Gain On Sale Of Ppe: -36094.00
REBN balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: 0.00
REBN income_statement (annual, 2023-12-31) — General And Administrative Expense: 8162523.00
REBN balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 56938.00
REBN balance_sheet (annual, 2023-12-31) — Gross PPE: 9171149.00
REBN income_statement (annual, 2023-12-31) — Gross Profit: 3619744.00
REBN cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 800.00
REBN income_statement (annual, 2023-12-31) — Interest Expense: 129480.00
REBN income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 129480.00
REBN cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 129000.00
REBN balance_sheet (annual, 2023-12-31) — Inventory: 185061.00
REBN balance_sheet (annual, 2023-12-31) — Invested Capital: 3279205.00
REBN cash_flow (annual, 2023-12-31) — Investing Cash Flow: -2413257.00
REBN cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 0.00
REBN cash_flow (annual, 2023-12-31) — Issuance Of Debt: 2784628.00
REBN balance_sheet (annual, 2023-12-31) — Leases: 622516.00
REBN balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 3725153.00
REBN balance_sheet (annual, 2023-12-31) — Long Term Debt: 856682.00
REBN balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 4581835.00
REBN cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 2784628.00
REBN cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -47102.00
REBN balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 1458411.00
REBN cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 0.00
REBN balance_sheet (annual, 2023-12-31) — Net Debt: 2268498.00
REBN income_statement (annual, 2023-12-31) — Net Income: -4725123.00
REBN income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -4725123.00
REBN income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -4725123.00
REBN income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -4725123.00
REBN income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -4725123.00
REBN cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -4725123.00
REBN income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -4725123.00
REBN income_statement (annual, 2023-12-31) — Net Interest Income: -129480.00
REBN cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 2737526.00
REBN cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 2737526.00
REBN income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -129480.00
REBN balance_sheet (annual, 2023-12-31) — Net PPE: 8061018.00
REBN cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -2413257.00
REBN cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: 0.00
REBN balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 846406.00
REBN income_statement (annual, 2023-12-31) — Normalized EBITDA: -4289702.00
REBN income_statement (annual, 2023-12-31) — Normalized Income: -4689029.00
REBN cash_flow (annual, 2023-12-31) — Operating Cash Flow: -3179003.00
REBN income_statement (annual, 2023-12-31) — Operating Income: -4542779.00
REBN income_statement (annual, 2023-12-31) — Operating Revenue: 5508139.00
REBN balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 1866173.00
REBN balance_sheet (annual, 2023-12-31) — Other Current Assets: 359124.00
REBN balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 1576117.00
REBN income_statement (annual, 2023-12-31) — Other Gand A: 8162523.00
REBN income_statement (annual, 2023-12-31) — Other Income Expense: -45036.00
REBN cash_flow (annual, 2023-12-31) — Other Non Cash Items: 256618.00
REBN balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 425712.00
REBN income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -8942.00
REBN balance_sheet (annual, 2023-12-31) — Other Properties: 6649522.00
REBN balance_sheet (annual, 2023-12-31) — Payables: 632753.00
REBN balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 1244043.00
REBN balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
REBN income_statement (annual, 2023-12-31) — Pretax Income: -4717295.00
REBN balance_sheet (annual, 2023-12-31) — Properties: 0.00